# Novitium Pharma LLC – FDA Inspection, Mar 31, 2023

Source: https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/071be200-4a09-4449-947c-fe0d400d5cc8
Source feed: FDA_Inspections

> FDA inspection 1204308 of Novitium Pharma LLC, March 31, 2023. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204308
- Company Name: Novitium Pharma LLC
- Inspection Date: 2023-03-31
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1230049 - 2024-02-16
- FDA Inspection 1231393 - 2024-02-01
- FDA Inspection 1145707 - 2021-07-08
- [FDA Inspection 1080904 - 2019-02-04](https://www.keypedia.com/records/fda_inspections/novitium-pharma-llc/39280e41-44ce-4cff-83ec-fff6aa1e07c5)
- FDA Inspection 1067953 - 2018-09-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/juanita-p-versace/dca6c7fb-62ac-4b06-9c77-dbf52fc83422)
- [Issuing Officer](https://www.keypedia.com/people/naveen-b-kanthamneni/b6ac825f-1ec8-4857-b772-86ae2c6ea1cd)
- [Issuing Officer](https://www.keypedia.com/people/tanya-r-syffrard/a78a42b3-6cef-46d9-9698-ec6082956477)

Company: https://www.keypedia.com/companies/novitium-pharma-llc/056d60b0-f42a-4b34-987f-749ffff0520a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
